| Type of financial instrument | Financial instrument | ISIN code | Nature of transaction | Linked to a share option programme | Volume | Unit | Price per unit | Currency code | Transaction date | Trading venue |
|---|---|---|---|---|---|---|---|---|---|---|
| Subscription right | Oasmia Pharmaceutical AB - TR | SE0013460540 | Acquisition | 300,000 | Quantity | 1.453984 | SEK | 27/11/2019 | NASDAQ STOCKHOLM AB | |
| Subscription right | Oasmia Pharmaceutical AB - TR | SE0013460540 | Acquisition | 110,528 | Quantity | 1.622 | SEK | 27/11/2019 | NASDAQ STOCKHOLM AB | |
| Subscription right | Oasmia Pharmaceutical AB - TR | SE0013460540 | Acquisition | 400,000 | Quantity | 1.664332 | SEK | 27/11/2019 | NASDAQ STOCKHOLM AB | |
| Subscription right | Oasmia Pharmaceutical AB - TR | SE0013460540 | Acquisition | 89,472 | Quantity | 1.834047 | SEK | 27/11/2019 | NASDAQ STOCKHOLM AB |
| Financial instrument | ISIN code | Nature of transaction | Transaction date | Trading venue | Volume | Weighted average price |
|---|---|---|---|---|---|---|
| Oasmia Pharmaceutical AB - TR | SE0013460540 | Acquisition | 27/11/2019 | NASDAQ STOCKHOLM AB | 900,000 (Quantity) | 1.60588919 SEK |
| Total: | 900,000 |